Century Therapeutics Inc. (IPSC)

AI Score

Unlock

0.54

0.04 (8.00%)

At close: Apr 17, 2025, 3:59 PM

Century Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	58.44M	52.59M	41.46M	46.81M	47.32M	55.31M	64.44M	86.83M	84.27M	111.35M	112.79M	126.04M	56.45M	101.29M	272.28M	79.48M	27.21M
Short-Term Investments	130.85M	145.52M	154.94M	145.2M	125.41M	114.2M	91.96M	164.64M	231.23M	244.51M	265.97M	234.98M	166.43M	193.86M	125.29M	103.46M	48.54M
Long-Term Investments	30.82M	46.56M	76.06M	59.83M	91.08M	114.76M	144.58M	83.32M	51.85M	39.43M	50.61M	105.36M	135.91M	105.19M	42.47M	63.14M	1.05M
Other Long-Term Assets	3.3M	3.4M	541K	544K	541K	2.54M	2.53M	2.93M	3.24M	3.26M	3.48M	3.33M	3.49M	3.47M	3.83M	1.24M	1.24M
Receivables	1.52M	n/a	n/a	n/a	n/a	1.67M	1.71M	1.47M	780K	364K	n/a	n/a	250K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-1.67M	-1.71M	-1.47M	n/a	n/a	n/a	2.75M	-250K	2.34M	1.4M	1.95M	1.88M
Other Current Assets	860K	7.9M	7.08M	7.8M	3.5M	126K	160K	202K	462K	629K	2.67M	3.42M	3.42M	3.04M	2.06M	2.36M	3.04M
Total Current Assets	194.05M	206.01M	203.48M	199.81M	176.99M	173.7M	161.28M	255.93M	319.72M	361.64M	383.79M	365.26M	228.15M	300.4M	402.61M	185.3M	78.8M
Property-Plant & Equipment	90.85M	94.11M	97.97M	88.32M	92.08M	106.54M	108.76M	114.05M	111.73M	107.43M	94.7M	76.35M	69.82M	60.66M	46.71M	33.12M	15.38M
Goodwill & Intangibles	34.2M	38.53M	38.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.46M	9.39M
Total Long-Term Assets	159.16M	182.61M	212.97M	148.69M	183.7M	223.85M	255.88M	200.29M	166.82M	150.11M	148.79M	185.05M	209.22M	169.33M	93.02M	100.76M	27.98M
Total Assets	353.22M	388.62M	416.45M	348.51M	360.69M	397.55M	417.16M	456.23M	486.54M	511.75M	532.58M	550.31M	437.38M	469.73M	495.63M	286.06M	106.78M
Account Payables	3.08M	2.6M	3.36M	3.43M	2.74M	5.93M	3.63M	3.48M	5.45M	5.68M	4.05M	9.89M	7.6M	11.64M	13.43M	8.82M	8.08M
Deferred Revenue	109.16M	3.57M	4.36M	4.61M	4.37M	3.87M	6.94M	6.5M	7.15M	7.57M	7.82M	6.38M	5.32M	6.5M	6.17M	3.16M	3.74M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10.3M	6.5M	4.04M	1.59M	n/a	1.04M	n/a	n/a	n/a	n/a
Other Current Liabilities	157K	3.68M	3.17M	2.94M	2.72M	2.18M	2.46M	3.69M	3.17M	3.92M	4.23M	1.1M	980K	966K	966K	281K	n/a
Total Current Liabilities	129.78M	19.82M	19.16M	16.07M	17.85M	20.43M	19.16M	27.68M	29.82M	26.91M	21.57M	21.98M	15.65M	19.87M	21.23M	12.91M	12.11M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.74M	6.14M	8.5M	10.02M	8.9M	9.87M	9.79M	9.71M	9.64M
Other Long-Term Liabilities	8.74M	9M	9.33M	20K	56K	201K	361K	433K	718K	971K	1.22M	1.47M	2.02M	2.25M	2.27M	340.24M	179.76M
Total Long-Term Liabilities	62.07M	173.11M	175.18M	154.56M	158.09M	157.89M	150.43M	151.37M	153.99M	154.64M	153.06M	141.67M	25.48M	26.87M	26.81M	364.7M	201.08M
Total Liabilities	191.85M	192.93M	194.34M	170.62M	175.94M	178.32M	169.59M	179.05M	183.81M	181.55M	174.63M	163.64M	41.14M	46.74M	48.03M	377.61M	213.19M
Total Debt	53.83M	54.6M	56.38M	46.47M	48.17M	45.53M	42.02M	51.47M	49.41M	47.27M	41.25M	25.04M	23.46M	25.25M	25.13M	25.05M	21.55M
Common Stock	9K	9K	8K	6K	6K	6K	6K	6K	6K	6K	6K	6K	5K	5K	5K	1K	1K
Retained Earnings	-782.34M	-746.27M	-715.04M	-683.83M	-655.77M	-616.37M	-583.65M	-550.36M	-519.1M	-487.42M	-456.67M	-425.68M	-388.17M	-359.97M	-333.96M	-310.69M	-292.34M
Comprehensive Income	324K	758K	-309K	-241K	108K	-1.3M	-1.21M	-1.27M	-2.46M	-3.6M	-3.43M	-2.64M	-650K	-63K	-3K	-26K	-3K
Shareholders Equity	161.36M	195.69M	222.1M	177.88M	184.75M	219.23M	247.57M	277.18M	302.74M	330.2M	357.95M	386.66M	396.24M	422.99M	447.6M	-91.56M	-106.41M
Total Investments	161.67M	192.08M	231.01M	205.03M	216.49M	228.96M	236.54M	247.95M	283.09M	283.94M	316.58M	340.34M	166.43M	299.05M	167.76M	166.6M	49.59M